People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Biotechnology, Other, Software / Tech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Carlsmed, Inc. | — | Biotechnology | Series C | $109.1M | $646.1M | 2019 |
| Arstasis Inc | — | Other | Series B | $102.3M | $274.1M | 2009 |
| Paragonix Technologies, Inc. | — | Software / Tech | Series B | $23.7M | $282.5M | 2023 |
| Zelegent, Inc. | — | Other Health Care | Seed | $3.1M | $3.5M | 2015 |
| Insightful Instruments Inc. | — | Other | Seed | $2.0M | $11.3M | 2023 |
ALEXANDER ARROW at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside ALEXANDER ARROW on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Root | 1 | 16 |
| Robert Grant | 1 | 12 |
| Kevin Sidow | 1 | 7 |
| ROBERT CROCE | 1 | 7 |
| Bosun Hau | 1 | 6 |
| Robert Mittendorff | 1 | 5 |
| David Auth | 1 | 5 |
| John McDermott | 1 | 5 |
| Lewis C. Pell | 1 | 5 |
| ROGER GUIDI | 1 | 5 |
| Glen D. Nelson | 1 | 4 |
| Philip Young | 1 | 4 |
| David C. Auth | 1 | 4 |
| Neil Devani | 1 | 3 |
| GLEN NELSON | 1 | 3 |
| Niel F. Starksen | 1 | 2 |
| Michael C. Chuisano | 1 | 2 |
| Samuel E. Navarro | 1 | 2 |
| Jeffrey Roh | 1 | 2 |
| John Cammett | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.